RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian Infants

• Status: Terminated
• Trial end date: 1999-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this trial is to evaluate the efficacy of weekly iron supplementation and the efficacy of malaria chemoprophylaxis from 2 to 12 months of age in infants living in an area of intense and perennial malaria transmission

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hospital Clinic of Barcelona
• Collaborators: Agencia Española de Cooperación Internacional; World Health Organization
• Treatments: Dapsone; Iron; Pyrimethamine

Criteria

Inclusion Criteria:

• Born in San Francis Designated District Hospital of Ifakara

Exclusion Criteria:

• Obvious severe congenital malformation such as: spina bifida, hydrocephalus or anencepahlus

• Twins

• Birth weight < 1,5 kg

• Clinical signs of cerebral asphyxia

• Clinical signs of neonatal or congenital infection

• Mother unreliable (deaf, mentally handicapped)